SALEHA BAIG: Open Payments
NPI 1902857907 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 6 payments from 5 companies in 2025. Trend: 2023 $339 · 2024 $270 · 2025 $200
Food & beverage: $123Education: $77
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $107 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Almatica Pharma LLC | 1 | $15 |
Products named: AUSTEDO XR, COBENFY, Jornay PM, INGREZZA, LOREEV XR.
Industry payments across NV — which companies pay providers there.
